Global Viral Gene Therapy Supply, Demand and Key Producers, 2023-2029

Description

The global Viral Gene Therapy market size is expected to reach $ 21600 million by 2029, rising at a market growth of 16.7% CAGR during the forecast period (2023-2029).

A robust gene therapy pipeline is expected to boost the gene therapy market growth in the forecast period.

Gene therapy is the treatment of a genetic disease by the introduction of specific cell function-altering genetic material into a patient. The key step in gene therapy is efficient gene delivery to the target tissue/cells, which is carried out by gene delivery vehicles called vectors.

This report studies the global Viral Gene Therapy demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Viral Gene Therapy, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Viral Gene Therapy that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Viral Gene Therapy total market, 2018-2029, (USD Million)
Global Viral Gene Therapy total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Viral Gene Therapy total market, key domestic companies and share, (USD Million)
Global Viral Gene Therapy revenue by player and market share 2018-2023, (USD Million)
Global Viral Gene Therapy total market by Type, CAGR, 2018-2029, (USD Million)
Global Viral Gene Therapy total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Viral Gene Therapy market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Biogen, Catalent, Gilead Sciences, Sarepta Therapeutics, Novartis, Amgen, Ionis Pharmaceuticals and Spark Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Viral Gene Therapy market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Viral Gene Therapy Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Viral Gene Therapy Market, Segmentation by Type
    Integrating Viral Vectors
    Non-Integrating Viral Vectors

Global Viral Gene Therapy Market, Segmentation by Application
    Metabolic Diseases
    Cardiovascular Diseases
    Muscular Diseases
    Hematologic Diseases
    Ophthalmologic Diseases
    Infectious Diseases
    Others

Companies Profiled:
    Lonza
    Biogen
    Catalent
    Gilead Sciences
    Sarepta Therapeutics
    Novartis
    Amgen
    Ionis Pharmaceuticals
    Spark Therapeutics
    Shanghai Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics

Key Questions Answered
1. How big is the global Viral Gene Therapy market?
2. What is the demand of the global Viral Gene Therapy market?
3. What is the year over year growth of the global Viral Gene Therapy market?
4. What is the total value of the global Viral Gene Therapy market?
5. Who are the major players in the global Viral Gene Therapy market?

Table of Contents

1 Supply Summary
    1.1 Viral Gene Therapy Introduction
    1.2 World Viral Gene Therapy Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Viral Gene Therapy Total Market by Region (by Headquarter Location)
        1.3.1 World Viral Gene Therapy Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Viral Gene Therapy Market Size (2018-2029)
        1.3.3 China Viral Gene Therapy Market Size (2018-2029)
        1.3.4 Europe Viral Gene Therapy Market Size (2018-2029)
        1.3.5 Japan Viral Gene Therapy Market Size (2018-2029)
        1.3.6 South Korea Viral Gene Therapy Market Size (2018-2029)
        1.3.7 ASEAN Viral Gene Therapy Market Size (2018-2029)
        1.3.8 India Viral Gene Therapy Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Viral Gene Therapy Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Viral Gene Therapy Major Market Trends

2 Demand Summary
    2.1 World Viral Gene Therapy Consumption Value (2018-2029)
    2.2 World Viral Gene Therapy Consumption Value by Region
        2.2.1 World Viral Gene Therapy Consumption Value by Region (2018-2023)
        2.2.2 World Viral Gene Therapy Consumption Value Forecast by Region (2024-2029)
    2.3 United States Viral Gene Therapy Consumption Value (2018-2029)
    2.4 China Viral Gene Therapy Consumption Value (2018-2029)
    2.5 Europe Viral Gene Therapy Consumption Value (2018-2029)
    2.6 Japan Viral Gene Therapy Consumption Value (2018-2029)
    2.7 South Korea Viral Gene Therapy Consumption Value (2018-2029)
    2.8 ASEAN Viral Gene Therapy Consumption Value (2018-2029)
    2.9 India Viral Gene Therapy Consumption Value (2018-2029)

3 World Viral Gene Therapy Companies Competitive Analysis
    3.1 World Viral Gene Therapy Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Viral Gene Therapy Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Viral Gene Therapy in 2022
        3.2.3 Global Concentration Ratios (CR8) for Viral Gene Therapy in 2022
    3.3 Viral Gene Therapy Company Evaluation Quadrant
    3.4 Viral Gene Therapy Market: Overall Company Footprint Analysis
        3.4.1 Viral Gene Therapy Market: Region Footprint
        3.4.2 Viral Gene Therapy Market: Company Product Type Footprint
        3.4.3 Viral Gene Therapy Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Viral Gene Therapy Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Viral Gene Therapy Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Viral Gene Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Viral Gene Therapy Consumption Value Comparison
        4.2.1 United States VS China: Viral Gene Therapy Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Viral Gene Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Viral Gene Therapy Companies and Market Share, 2018-2023
        4.3.1 United States Based Viral Gene Therapy Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Viral Gene Therapy Revenue, (2018-2023)
    4.4 China Based Companies Viral Gene Therapy Revenue and Market Share, 2018-2023
        4.4.1 China Based Viral Gene Therapy Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Viral Gene Therapy Revenue, (2018-2023)
    4.5 Rest of World Based Viral Gene Therapy Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Viral Gene Therapy Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Viral Gene Therapy Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Viral Gene Therapy Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Integrating Viral Vectors
        5.2.2 Non-Integrating Viral Vectors
    5.3 Market Segment by Type
        5.3.1 World Viral Gene Therapy Market Size by Type (2018-2023)
        5.3.2 World Viral Gene Therapy Market Size by Type (2024-2029)
        5.3.3 World Viral Gene Therapy Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Viral Gene Therapy Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Metabolic Diseases
        6.2.2 Cardiovascular Diseases
        6.2.3 Muscular Diseases
        6.2.4 Hematologic Diseases
        6.2.5 Hematologic Diseases
        6.2.6 Infectious Diseases
        6.2.7 Others
    6.3 Market Segment by Application
        6.3.1 World Viral Gene Therapy Market Size by Application (2018-2023)
        6.3.2 World Viral Gene Therapy Market Size by Application (2024-2029)
        6.3.3 World Viral Gene Therapy Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Lonza
        7.1.1 Lonza Details
        7.1.2 Lonza Major Business
        7.1.3 Lonza Viral Gene Therapy Product and Services
        7.1.4 Lonza Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Lonza Recent Developments/Updates
        7.1.6 Lonza Competitive Strengths & Weaknesses
    7.2 Biogen
        7.2.1 Biogen Details
        7.2.2 Biogen Major Business
        7.2.3 Biogen Viral Gene Therapy Product and Services
        7.2.4 Biogen Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Biogen Recent Developments/Updates
        7.2.6 Biogen Competitive Strengths & Weaknesses
    7.3 Catalent
        7.3.1 Catalent Details
        7.3.2 Catalent Major Business
        7.3.3 Catalent Viral Gene Therapy Product and Services
        7.3.4 Catalent Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Catalent Recent Developments/Updates
        7.3.6 Catalent Competitive Strengths & Weaknesses
    7.4 Gilead Sciences
        7.4.1 Gilead Sciences Details
        7.4.2 Gilead Sciences Major Business
        7.4.3 Gilead Sciences Viral Gene Therapy Product and Services
        7.4.4 Gilead Sciences Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Gilead Sciences Recent Developments/Updates
        7.4.6 Gilead Sciences Competitive Strengths & Weaknesses
    7.5 Sarepta Therapeutics
        7.5.1 Sarepta Therapeutics Details
        7.5.2 Sarepta Therapeutics Major Business
        7.5.3 Sarepta Therapeutics Viral Gene Therapy Product and Services
        7.5.4 Sarepta Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Sarepta Therapeutics Recent Developments/Updates
        7.5.6 Sarepta Therapeutics Competitive Strengths & Weaknesses
    7.6 Novartis
        7.6.1 Novartis Details
        7.6.2 Novartis Major Business
        7.6.3 Novartis Viral Gene Therapy Product and Services
        7.6.4 Novartis Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Novartis Recent Developments/Updates
        7.6.6 Novartis Competitive Strengths & Weaknesses
    7.7 Amgen
        7.7.1 Amgen Details
        7.7.2 Amgen Major Business
        7.7.3 Amgen Viral Gene Therapy Product and Services
        7.7.4 Amgen Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Amgen Recent Developments/Updates
        7.7.6 Amgen Competitive Strengths & Weaknesses
    7.8 Ionis Pharmaceuticals
        7.8.1 Ionis Pharmaceuticals Details
        7.8.2 Ionis Pharmaceuticals Major Business
        7.8.3 Ionis Pharmaceuticals Viral Gene Therapy Product and Services
        7.8.4 Ionis Pharmaceuticals Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Ionis Pharmaceuticals Recent Developments/Updates
        7.8.6 Ionis Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 Spark Therapeutics
        7.9.1 Spark Therapeutics Details
        7.9.2 Spark Therapeutics Major Business
        7.9.3 Spark Therapeutics Viral Gene Therapy Product and Services
        7.9.4 Spark Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Spark Therapeutics Recent Developments/Updates
        7.9.6 Spark Therapeutics Competitive Strengths & Weaknesses
    7.10 Shanghai Sunway Biotech
        7.10.1 Shanghai Sunway Biotech Details
        7.10.2 Shanghai Sunway Biotech Major Business
        7.10.3 Shanghai Sunway Biotech Viral Gene Therapy Product and Services
        7.10.4 Shanghai Sunway Biotech Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Shanghai Sunway Biotech Recent Developments/Updates
        7.10.6 Shanghai Sunway Biotech Competitive Strengths & Weaknesses
    7.11 SIBIONO
        7.11.1 SIBIONO Details
        7.11.2 SIBIONO Major Business
        7.11.3 SIBIONO Viral Gene Therapy Product and Services
        7.11.4 SIBIONO Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 SIBIONO Recent Developments/Updates
        7.11.6 SIBIONO Competitive Strengths & Weaknesses
    7.12 AnGes
        7.12.1 AnGes Details
        7.12.2 AnGes Major Business
        7.12.3 AnGes Viral Gene Therapy Product and Services
        7.12.4 AnGes Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 AnGes Recent Developments/Updates
        7.12.6 AnGes Competitive Strengths & Weaknesses
    7.13 Orchard Therapeutics
        7.13.1 Orchard Therapeutics Details
        7.13.2 Orchard Therapeutics Major Business
        7.13.3 Orchard Therapeutics Viral Gene Therapy Product and Services
        7.13.4 Orchard Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 Orchard Therapeutics Recent Developments/Updates
        7.13.6 Orchard Therapeutics Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Viral Gene Therapy Industry Chain
    8.2 Viral Gene Therapy Upstream Analysis
    8.3 Viral Gene Therapy Midstream Analysis
    8.4 Viral Gene Therapy Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Viral Gene Therapy Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Viral Gene Therapy Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Viral Gene Therapy Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Viral Gene Therapy Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Viral Gene Therapy Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Viral Gene Therapy Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Viral Gene Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Viral Gene Therapy Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Viral Gene Therapy Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Viral Gene Therapy Players in 2022
    Table 12. World Viral Gene Therapy Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Viral Gene Therapy Company Evaluation Quadrant
    Table 14. Head Office of Key Viral Gene Therapy Player
    Table 15. Viral Gene Therapy Market: Company Product Type Footprint
    Table 16. Viral Gene Therapy Market: Company Product Application Footprint
    Table 17. Viral Gene Therapy Mergers & Acquisitions Activity
    Table 18. United States VS China Viral Gene Therapy Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Viral Gene Therapy Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Viral Gene Therapy Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Viral Gene Therapy Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Viral Gene Therapy Revenue Market Share (2018-2023)
    Table 23. China Based Viral Gene Therapy Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Viral Gene Therapy Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Viral Gene Therapy Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Viral Gene Therapy Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Viral Gene Therapy Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Viral Gene Therapy Revenue Market Share (2018-2023)
    Table 29. World Viral Gene Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Viral Gene Therapy Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Viral Gene Therapy Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Viral Gene Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Viral Gene Therapy Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Viral Gene Therapy Market Size by Application (2024-2029) & (USD Million)
    Table 35. Lonza Basic Information, Area Served and Competitors
    Table 36. Lonza Major Business
    Table 37. Lonza Viral Gene Therapy Product and Services
    Table 38. Lonza Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Lonza Recent Developments/Updates
    Table 40. Lonza Competitive Strengths & Weaknesses
    Table 41. Biogen Basic Information, Area Served and Competitors
    Table 42. Biogen Major Business
    Table 43. Biogen Viral Gene Therapy Product and Services
    Table 44. Biogen Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Biogen Recent Developments/Updates
    Table 46. Biogen Competitive Strengths & Weaknesses
    Table 47. Catalent Basic Information, Area Served and Competitors
    Table 48. Catalent Major Business
    Table 49. Catalent Viral Gene Therapy Product and Services
    Table 50. Catalent Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Catalent Recent Developments/Updates
    Table 52. Catalent Competitive Strengths & Weaknesses
    Table 53. Gilead Sciences Basic Information, Area Served and Competitors
    Table 54. Gilead Sciences Major Business
    Table 55. Gilead Sciences Viral Gene Therapy Product and Services
    Table 56. Gilead Sciences Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Gilead Sciences Recent Developments/Updates
    Table 58. Gilead Sciences Competitive Strengths & Weaknesses
    Table 59. Sarepta Therapeutics Basic Information, Area Served and Competitors
    Table 60. Sarepta Therapeutics Major Business
    Table 61. Sarepta Therapeutics Viral Gene Therapy Product and Services
    Table 62. Sarepta Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Sarepta Therapeutics Recent Developments/Updates
    Table 64. Sarepta Therapeutics Competitive Strengths & Weaknesses
    Table 65. Novartis Basic Information, Area Served and Competitors
    Table 66. Novartis Major Business
    Table 67. Novartis Viral Gene Therapy Product and Services
    Table 68. Novartis Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Novartis Recent Developments/Updates
    Table 70. Novartis Competitive Strengths & Weaknesses
    Table 71. Amgen Basic Information, Area Served and Competitors
    Table 72. Amgen Major Business
    Table 73. Amgen Viral Gene Therapy Product and Services
    Table 74. Amgen Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Amgen Recent Developments/Updates
    Table 76. Amgen Competitive Strengths & Weaknesses
    Table 77. Ionis Pharmaceuticals Basic Information, Area Served and Competitors
    Table 78. Ionis Pharmaceuticals Major Business
    Table 79. Ionis Pharmaceuticals Viral Gene Therapy Product and Services
    Table 80. Ionis Pharmaceuticals Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Ionis Pharmaceuticals Recent Developments/Updates
    Table 82. Ionis Pharmaceuticals Competitive Strengths & Weaknesses
    Table 83. Spark Therapeutics Basic Information, Area Served and Competitors
    Table 84. Spark Therapeutics Major Business
    Table 85. Spark Therapeutics Viral Gene Therapy Product and Services
    Table 86. Spark Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Spark Therapeutics Recent Developments/Updates
    Table 88. Spark Therapeutics Competitive Strengths & Weaknesses
    Table 89. Shanghai Sunway Biotech Basic Information, Area Served and Competitors
    Table 90. Shanghai Sunway Biotech Major Business
    Table 91. Shanghai Sunway Biotech Viral Gene Therapy Product and Services
    Table 92. Shanghai Sunway Biotech Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Shanghai Sunway Biotech Recent Developments/Updates
    Table 94. Shanghai Sunway Biotech Competitive Strengths & Weaknesses
    Table 95. SIBIONO Basic Information, Area Served and Competitors
    Table 96. SIBIONO Major Business
    Table 97. SIBIONO Viral Gene Therapy Product and Services
    Table 98. SIBIONO Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. SIBIONO Recent Developments/Updates
    Table 100. SIBIONO Competitive Strengths & Weaknesses
    Table 101. AnGes Basic Information, Area Served and Competitors
    Table 102. AnGes Major Business
    Table 103. AnGes Viral Gene Therapy Product and Services
    Table 104. AnGes Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. AnGes Recent Developments/Updates
    Table 106. Orchard Therapeutics Basic Information, Area Served and Competitors
    Table 107. Orchard Therapeutics Major Business
    Table 108. Orchard Therapeutics Viral Gene Therapy Product and Services
    Table 109. Orchard Therapeutics Viral Gene Therapy Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 110. Global Key Players of Viral Gene Therapy Upstream (Raw Materials)
    Table 111. Viral Gene Therapy Typical Customers
List of Figure
    Figure 1. Viral Gene Therapy Picture
    Figure 2. World Viral Gene Therapy Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Viral Gene Therapy Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Viral Gene Therapy Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Viral Gene Therapy Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Viral Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Viral Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Viral Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Viral Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Viral Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Viral Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Viral Gene Therapy Revenue (2018-2029) & (USD Million)
    Figure 13. Viral Gene Therapy Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Viral Gene Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Viral Gene Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Viral Gene Therapy by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Viral Gene Therapy Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Viral Gene Therapy Markets in 2022
    Figure 27. United States VS China: Viral Gene Therapy Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Viral Gene Therapy Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Viral Gene Therapy Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Viral Gene Therapy Market Size Market Share by Type in 2022
    Figure 31. Integrating Viral Vectors
    Figure 32. Non-Integrating Viral Vectors
    Figure 33. World Viral Gene Therapy Market Size Market Share by Type (2018-2029)
    Figure 34. World Viral Gene Therapy Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 35. World Viral Gene Therapy Market Size Market Share by Application in 2022
    Figure 36. Metabolic Diseases
    Figure 37. Cardiovascular Diseases
    Figure 38. Muscular Diseases
    Figure 39. Hematologic Diseases
    Figure 40. Ophthalmologic Diseases
    Figure 41. Infectious Diseases
    Figure 42. Others
    Figure 43. Viral Gene Therapy Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source

Companies Mentioned

Lonza
Biogen
Catalent
Gilead Sciences
Sarepta Therapeutics
Novartis
Amgen
Ionis Pharmaceuticals
Spark Therapeutics
Shanghai Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics